Spark Therapeutics is a publicly traded, late clinical-stage gene therapy company. Its investigational therapies have the potential to provide long-lasting effects, dramatically and positively changing the lives of patients with conditions where no, or only palliative, therapies exist.
Watchdog was engaged by Spark in 2017 to assist in the fit-out of their 24,000 square foot office space in the FMC Tower located in University City – Philadelphia. Spark was rapidly expanding and required additional space to increase their employee headcount as well as build out Research and Development laboratories for their gene therapy drugs.
Watchdog came onboard when construction was 10% complete. We took over the project for Spark and oversaw the remaining fit-out. Throughout the project, Watchdog provided full-time, on-site project management to execute this fast-paced project.
At completion of the FMC office fit out, Spark retained the Watchdog team to stay on in a facilities management role as well as manage renovations and daily operations within their existing offices. Our team remained on-site to help the growing organization establish the Corporate Facilities and Engineering Management protocols, develop internal procedures and act as a liaison between all internal teams / departments while managing a series of small-scale projects. During this time, Watchdog was managing three corporate office locations for Spark Therapeutics which has now grown to a total of five sites.
Watchdog continues to represent Spark as the company continues to expand their real estate footprint.